Sen. Hatch’s Take On Tavenner For CMS Chief: A Glimmer Of Hope For Approval?
This article was originally published in The Pink Sheet Daily
Executive Summary
Marilyn Tavenner is re-nominated for CMS administrator Feb.7. Her previous nomination languished in the Senate because of the fear that her nomination couldn’t muster the votes for approval, but a statement from the top Finance Committee Republican suggests more openness this time around.
You may also be interested in...
CMS Administrator-Nominee Tavenner Would Bring Leadership Continuity As ACA Implementation Continues
With the selection of Centers for Medicare and Medicaid Services Principal Deputy Administrator Marilyn Tavenner as Don Berwick’s successor, the Obama administration appears to be seeking leadership continuity with a candidate that has a good chance of gaining Senate confirmation.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.